Genetically decreased vitamin D and risk of Alzheimer disease

Neurology
Lauren E MokryJ Brent Richards

Abstract

To test whether genetically decreased vitamin D levels are associated with Alzheimer disease (AD) using mendelian randomization (MR), a method that minimizes bias due to confounding or reverse causation. We selected single nucleotide polymorphisms (SNPs) that are strongly associated with 25-hydroxyvitamin D (25OHD) levels (p < 5 × 10-8) from the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits (SUNLIGHT) Consortium (N = 33,996) to act as instrumental variables for the MR study. We measured the effect of each of these SNPs on 25OHD levels in the Canadian Multicentre Osteoporosis Study (CaMos; N = 2,347) and obtained the corresponding effect estimates for each SNP on AD risk from the International Genomics of Alzheimer's Project (N = 17,008 AD cases and 37,154 controls). To produce MR estimates, we weighted the effect of each SNP on AD by its effect on 25OHD and meta-analyzed these estimates using a fixed-effects model to provide a summary effect estimate. The SUNLIGHT Consortium identified 4 SNPs to be genome-wide significant for 25OHD, which described 2.44% of the variance in 25OHD in CaMos. All 4 SNPs map to genes within the vitamin D metabolic pathway. MR analyses demonstrated that a 1-SD decrea...Continue Reading

Citations

Jun 9, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Susanna C LarssonInternational Parkinson's Disease Genomics Consortium (IPDGC)
Mar 23, 2018·Journal of Medicinal Food·Alice Barros CâmaraRodrigo Juliani Siqueira Dalmolin
Sep 12, 2017·Canadian Journal of Physiology and Pharmacology·Nada K SedkyMohamed Zakaria Gad
Apr 18, 2018·Journal of Alzheimer's Disease : JAD·Jen-Hung WangRaymond Y Lo
Jun 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tongxing WangYongxiang Zhang
Oct 16, 2018·Expert Review of Endocrinology & Metabolism·Barbara J Boucher
Mar 15, 2019·The British Journal of Psychiatry : the Journal of Mental Science·Tom C RussJohn M Starr
May 31, 2019·Neurological Research·Giulia BivonaMarcello Ciaccio
Oct 16, 2018·Endocrine Reviews·Roger BouillonJohn Bilezikian
Jul 18, 2019·Journal of Molecular Neuroscience : MN·Afsane BahramiMajid Ghayour-Mobarhan
Jul 18, 2019·American Journal of Alzheimer's Disease and Other Dementias·Mustafa GokceGulsen Babacan Yildiz
Feb 16, 2018·Nutritional Neuroscience·Ahmad JayediSakineh Shab-Bidar
Dec 7, 2018·Human Molecular Genetics·Jue-Sheng OngStuart MacGregor
Feb 7, 2018·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·A F BaisA M Heikkilä
Jun 6, 2018·Journal of Alzheimer's Disease : JAD·Elżbieta KuźmaDavid J Llewellyn
Mar 3, 2020·Journal of Alzheimer's Disease : JAD·Haihua ZhangGuiyou Liu
Jun 17, 2020·Journal of Alzheimer's Disease : JAD·Yating HeGuiyou Liu
Dec 20, 2017·International Journal of Molecular Sciences·Marcus O W GrimmTobias Hartmann
Aug 29, 2018·Journal of Alzheimer's Disease : JAD·Hongjuan Yuan, Wenjie Yang
Apr 2, 2019·Nature Human Behaviour·Tom C RussMQ Data Science group
Oct 19, 2017·Scientific Reports·Jane MaddockElina Hyppönen
Mar 24, 2017·Human Molecular Genetics·Giuseppe GalloneAntonio J Berlanga-Taylor
Oct 6, 2020·Journal of the American Geriatrics Society·Luke C PillingDavid Melzer

Related Concepts

Familial Alzheimer Disease (FAD)
Post-Traumatic Osteoporosis
Vitamin D
Nutraceuticals
Single Nucleotide Polymorphism
Mendelian Randomization Analysis
Alzheimer's Disease
Cognition
Genes
Genome

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.